From the Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark (S.I., W.M., S. Sciarretta, M.A., P.Z., R.M., N.F., S.-i.O., M.N., D.P.D.R., L.-H.X., J.S.).
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (S.I., H.S.).
Circ Res. 2019 Jan 18;124(2):292-305. doi: 10.1161/CIRCRESAHA.118.314048.
The Hippo pathway plays an important role in determining organ size through regulation of cell proliferation and apoptosis. Hippo inactivation and consequent activation of YAP (Yes-associated protein), a transcription cofactor, have been proposed as a strategy to promote myocardial regeneration after myocardial infarction. However, the long-term effects of Hippo deficiency on cardiac function under stress remain unknown.
We investigated the long-term effect of Hippo deficiency on cardiac function in the presence of pressure overload (PO).
We used mice with cardiac-specific homozygous knockout of WW45 (WW45cKO), in which activation of Mst1 (Mammalian sterile 20-like 1) and Lats2 (large tumor suppressor kinase 2), the upstream kinases of the Hippo pathway, is effectively suppressed because of the absence of the scaffolding protein. We used male mice at 3 to 4 month of age in all animal experiments. We subjected WW45cKO mice to transverse aortic constriction for up to 12 weeks. WW45cKO mice exhibited higher levels of nuclear YAP in cardiomyocytes during PO. Unexpectedly, the progression of cardiac dysfunction induced by PO was exacerbated in WW45cKO mice, despite decreased apoptosis and activated cardiomyocyte cell cycle reentry. WW45cKO mice exhibited cardiomyocyte sarcomere disarray and upregulation of TEAD1 (transcriptional enhancer factor) target genes involved in cardiomyocyte dedifferentiation during PO. Genetic and pharmacological inactivation of the YAP-TEAD1 pathway reduced the PO-induced cardiac dysfunction in WW45cKO mice and attenuated cardiomyocyte dedifferentiation. Furthermore, the YAP-TEAD1 pathway upregulated OSM (oncostatin M) and OSM receptors, which played an essential role in mediating cardiomyocyte dedifferentiation. OSM also upregulated YAP and TEAD1 and promoted cardiomyocyte dedifferentiation, indicating the existence of a positive feedback mechanism consisting of YAP, TEAD1, and OSM.
Although activation of YAP promotes cardiomyocyte regeneration after cardiac injury, it induces cardiomyocyte dedifferentiation and heart failure in the long-term in the presence of PO through activation of the YAP-TEAD1-OSM positive feedback mechanism.
Hippo 通路通过调节细胞增殖和凋亡在确定器官大小方面发挥重要作用。已经提出 Hippo 失活和随后的 Yes 相关蛋白(YAP)的激活(转录共因子)作为心肌梗死后促进心肌再生的策略。然而,Hippo 缺乏对压力超负荷(PO)下心脏功能的长期影响尚不清楚。
我们研究了 Hippo 缺乏对 PO 存在下心脏功能的长期影响。
我们使用心脏特异性 WW45 纯合敲除(WW45cKO)的小鼠,其中 Hippo 通路的上游激酶 Mst1(哺乳动物不育 20 样激酶 1)和 Lats2 的激活由于支架蛋白的缺失而被有效抑制。我们在所有动物实验中均使用 3 至 4 月龄的雄性小鼠。我们对 WW45cKO 小鼠进行了长达 12 周的横主动脉缩窄。在 PO 期间,WW45cKO 小鼠的心肌细胞中核 YAP 水平更高。出乎意料的是,尽管凋亡减少和激活的心肌细胞细胞周期再进入,PO 诱导的心脏功能障碍的进展在 WW45cKO 小鼠中加剧。在 PO 期间,WW45cKO 小鼠表现出心肌细胞肌节排列紊乱和参与心肌细胞去分化的 TEAD1(转录增强因子)靶基因的上调。YAP-TEAD1 途径的遗传和药理学失活减少了 WW45cKO 小鼠的 PO 诱导的心脏功能障碍,并减轻了心肌细胞去分化。此外,YAP-TEAD1 途径上调了 OSM(oncostatin M)和 OSM 受体,它们在介导心肌细胞去分化中起重要作用。OSM 还上调了 YAP 和 TEAD1,并促进了心肌细胞去分化,表明 YAP、TEAD1 和 OSM 之间存在正反馈机制。
尽管 YAP 的激活促进了心脏损伤后的心肌再生,但它通过激活 YAP-TEAD1-OSM 正反馈机制,在 PO 存在下长期诱导心肌细胞去分化和心力衰竭。